Advertisement
Person › Details
Roch Doliveux (UCB S.A. (Euronext: UCB))
Doliveux, Roch (UCB 200602 CEO)
Organisation | UCB S.A. (Euronext: UCB) | |
Group | UCB (Group) | |
Record changed: 2024-03-11 |
Advertisement
More documents for Roch Doliveux
- [1] Pierre Fabre Laboratories. (1/10/24). "Press Release: Hervé Hoppenot, Incyte CEO, Is Appointed on the Board of Pierre Fabre Laboratories". Castres....
- [2] Oxford Biomedica plc. (12/14/22). "Press Release: Oxford Biomedica Solutions Forms New Partnerships with Three Biotechnology Companies". Oxford....
- [3] Oxford Biomedica plc. (11/22/22). "Press Release: Oxford Biomedica Appoints Dr Frank Mathias as Chief Executive Officer". Oxford....
- [4] Oxford Biomedica plc. (3/11/22). "Press Release: Oxford Biomedica Broadens Its Viral Vector Capabilities with the Launch of Oxford Biomedica Solutions, a Full Scope AAV Business in Boston, Following Closing of Its Deal with Homology". Oxford....
- [5] Oxford Biomedica plc. (7/15/21). "Press Release: Oxford Biomedica Appoints Dr. Michael Hayden as Non-Executive Director". Oxford....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top